All News

Our content has now moved to our new Global Pharma Insights website, providing the very latest news and information covering all aspects of the pharmaceutical supply chain. Please click the link below to access this article.

As biopharma heads towards a new decade, extracting value from innovation remains a key theme in medicines development. However, rather than accepting the traditional model of novel treatments via the R&D pipeline as the innovative focus, the industry ...

China is stepping up its efforts to produce and ship active pharmaceutical ingredients (APIs), with a focus on meeting international demand, particularly for those showing potential to treat the COVID-19 disease, according to Chinese officials on Tuesd...

The Ritedose Corporation, a contract development and manufacturing organisation (CDMO) with a focus on inhalation and ophthalmic products, has partnered with ChargePoint Technology to ensure the sterility of its drug substance mixing process.

The patent covers the crosslinking of certain carrier molecules, for example, antibodies, via specific binding sites to amatoxins.

Study data support blood test's ability to detect 50 types of cancer and identify where in the body the cancer is located.

Specialist cleanroom microbiology solutions company offers the new SAS Super Pinocchio CR compressed air sampling device.

Joint venture between Spinview and VR Media Technology creates device that provides accurate and fast detection of infectious people with far greater clarity than any single parameter test available today.

The European Medicines Agency (EMA) said Monday it will only issue electronically signed and authenticated certificates for human and veterinary medicines in place of printed ones so it can continue to provide the documents during the COVID-19 pandemic...

Indian contract development and manufacturing organisation, Suven Pharmaceuticals, has warned it cannot export finished products due to a shortage of raw materials following the country’s recent lockdown to fight the COVID-19 pandemic.

The Women in Leadership Forum is a networking and knowledge-sharing event for pharma executives to share experiences and strategies for bringing diversity and equal opportunities to the industry.

Together, the companies will provide APAC markets with a cost-effective alternative to the largest-selling blockbuster medicine worldwide.

Collaboration with MedPharm delivers data profiling new XF‐platform drug formulations as potential treatments for dermal and ocular infections.

The Contract Development and Manufacturing Organization (CDMO) and technology provider will use its CHO.RiGHT expression platform for high-titer cell line development.

A look at how India has achieved pharmaceutical self-sufficiency over the years -  taking steps to become a global leader not only in the production of low-cost generic medicines but increasingly, end-to-end drug discovery and development.

The TheraPEAK SfAAV Medium is specifically designed to support the development of safe, scalable, gene therapies.

The new formulation offers patients in Europe an alternative route of administration of the only fixed antiemetic combination targeting two distinct CINV pathways in a single dose.

CDMOs build capacity to capitalise on biologics boom

Fierce competition in the low cost, high volume API sector is forcing suppliers to invest in capacity and accelerate throughout. 

Despite consolidation, competition between manufacturers is fierce and the generic drug market continues to grow.

Fujifilm Diosynth Biotechnologies will triple microbial production capacity at its UK Teesside facility after joint owner Fujifilm Corporation pledged to invest 9 billion yen (USD83 million) in the biologics focused CDMO.

Cell and gene focused CDMO Oxford Biomedica (OXB) has signed a licence and clinical supply agreement which could be worth up to USD227 million with Juno Therapeutics, the firms announced Wednesday.

A new contract development and manufacturing organisation to support cell and gene developers with process development and production of viral vectors has been launched by bioprocessing provider Univercells.

The ability of pharmaceutical packaging solutions to add value and improve the experience for both patients and healthcare professionals was a core theme at Pharmapack Europe 2020, with an emphasis on how the industry can identify opportunities via tec...

The worldwide inter-dependency of pharmaceutical manufacturing is highlighted by the ongoing Coronavirus situation. How can the global supply of diagnostic kits, drugs, medical supplies, and equipment be sustained to treat patients in the face of suppl...

Recognizing the importance of empathetic leadership to business growth and sustainability

Fujifilm Diosynth Biotechnologies has appointed Christine Vannais as chief operating officer at its North Carolina site, the biologics focused CDMO said Monday.

Organizers secure three new dates for events in Japan, South East Asia and North America in response to COVID-19.

Company awarded US$5 million grant for clinical study of measles and rubella vaccination using Vaxxas’ high-density, micro-array patch.

This documentation will enable customers worldwide to leverage the D-Flex disposable pen system for their combination product development.

The US Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for Thermo Fisher Scientific’s diagnostic test for coronavirus, the contract development and manufacturing organisation said Monday.

Postnova Analytics' CF2000 Centrifugal Field Flow Fractionation (CF3) system is delivering exciting new data to scientists developing drug delivery systems.

The trial is the first controlled trial in the US to evaluate the effect of IL-6 inhibition prospectively in COVID-19 patients.

A web-based means of finding the cleaning products to meet the challenges posed by cleanroom operations.

Is the pharma industry making the most of AI’s potential when it comes to accelerating and enhancing pharmaceutical drug development?

Indian pharmaceutical supply chain disruption could be far greater than the China environmental regulation-induced shortfall of 2017 If the COVID-19 outbreak is not contained within the next three months, credit ratings agency India Ratings and Researc...

New modalities, new methods and new thinking to solve old problems

Japanese bio-focused CDMO Fujifilm Diosynth Biotechnologies has announced a change of leadership with president and COO, Martin Meeson taking over as CEO, replacing Steve Bagshaw, who is retiring.

Following the 2018 FDA approval of GW Pharmaceuticals’ Epidiolex®, there has been increased interest in the development of cannabinoid-derived drug substances for innovative new therapies. We examine the state of the market and future potenti...

Pipeline diversification, emerging therapies and shifting customer demands are the real dynamics reshaping the contract manufacturing market, according to experts.

Appropriate asthma and COPD patients provided with a "more affordable alternative to appropriate".

Netherlands-based specialty pharmaceutical company Pharming has received US Food and Drug Administration (FDA) approval for its new biologics facility in the Netherlands which it says will ensure sufficient manufacturing capacity for its acute heredita...

Company launches BIOSTAT STR Generation 3 bioreactor with BIOBRAIN automation platform.

Phase III study evaluating Empliciti plus Revlimid and dexamethasone in patients with newly diagnosed, untreated multiple myeloma fails to meet primary endpoint.

Active pharmaceutical ingredients (APIs) nanoformed using the CESS process demonstrate promise for overcoming solubility and bioavailability challenges.

CDMO Bora Pharmaceuticals said Monday it has agreed to acquire GlaxoSmithKline's Mississauga, Ontario (Canada) facility, which produces approximately 50 different products for more than 100 markets worldwide.

Sai Life Sciences won two awards at the recently concluded 2nd SCMPro India Procurement Leadership Forum & Awards 2020, in the categories of Supply Risk Management and Supplier Relationship Management.

Sai Life Sciences received the ISO 14001:2015 (Environment management system) and ISO 45001:2018 (Occupational health and safety management system) certification for its R&D centre (Unit II), Manufacturing facility (Unit IV) and Corporate office.

Systech International (“Systech”) announced today that it has entered into a definitive agreement to be acquired by Dover Corporation.

FLAVOXALE® is a unique ingredient derived from the combination of an exclusive propolis extract (M.E.D. propolis), manuka honey and manuka essential oil.

Biotech firm Gilead Sciences said Monday it is set to acquire clinical-stage oncology specialist Forty Seven in a transaction worth $4.9 billion.

The company’s immediate priority is to address the opioid crisis by developing a non-hallucinogenic version of the psychedelic ibogaine.

Luxembourg-based phytochemical and chemical pharmaceutical manufacturing and distribution group, C2 Pharma, has expanded its advisory board with a new member.

Fujifilm Diosynth Biotechnologies (FDB) has started work on capacity expansion to support high throughput and large volume gene therapy products at its manufacturing facility in Texas, US, the Japanese bio-focused contract research and development orga...

The US Food and Drug Administration (FDA) accepts for review Pfizer and Eli Lilly's Biologics License Application (BLA) for tanezumab — a non-opioid treatment for patients with chronic pain due to moderate-to-severe osteoarthritis.

The White House task force and the US President will meet drug makers this afternoon to discuss "progress on a vaccine and cure".

With the world’s attitude to tackling climate change arguably the global number one hot topic of 2019, the issue of sustainability is an emerging theme in pharmaceutical packaging.

The US Food and Drug Administration has reported the first case of a pharmaceutical drug shortage directly related to the global coronavirus (COVID-19) outbreak that is threatening to reach pandemic status.

Rescheduling will ensure all stakeholders can take part in a successful exhibition and conference.

A cooperation agreement between German pharma firm Merck KGaA and additive manufacturing specialist AMCM on 3D printing of tablets could eventually lead to scalable active pharmaceutical ingredient (API) formulation and faster, cheaper production, the ...

Agreement gives BIA Separations access to proprietary technology to better preserve integrity, infectivity and potency of immunoaffinity-purified viral vectors for gene therapy.

Chinese CDMO WuXi Biologics has linked up with San Francisco biotech firm Vir Biotechnology to develop and manufacture human monoclonal antibodies (mAbs) to potentially treat coronavirus disease (COVID-19), the two firms said Tuesday.

Sai Life Sciences, today announced the appointment of Dr. Dean Edney as Senior Vice President and Global Head of Process Research & Development.

The study will evaluate the efficacy of SJX-653 in reducing the frequency and severity of VMS due to menopause, as well as improving measures of sleep and quality of life.

Unlocking the potential of Raman spectroscopy as a high throughput analytical technique for monitoring cell culture in mini bioreactors.

Cell and gene therapy service providers TrakCel and Ori Biotech have agreed a strategic partnership whereby TrakCel’s tracking software will be closely integrated with Ori’s automated platform to give users greater live supply chain visibility within c...

Italy’s Dipharma Francis has completed construction of a new cGMP manufacturing suite at its US subsidiary, Kalexsyn, strengthening its service offering and ensuring continuity across the product lifecycle from preclinical to commercialisation , the co...

Sanofi's plans to create a European company to manufacture and market active pharmaceutical ingredients (APIs) should help to balance the region's heavy reliance on sourcing them from Asian markets, the French pharmaceutical firm said Monday.

Identifying areas of unmet need to guide R&D strategy and shape drug pipelines

Beovu is the only anti-VEGF treatment approved in Europe for wet AMD that offers the option to start eligible patients on 3-month dosing intervals immediately after the loading phase.

ScentSational Technologies has selected CPHI on May 5, 2020 at the Philadelphia Convention Center to enable attendees to experience the Company’s latest innovation in multi-sensory branding for Dietary Supplements.

Tufts Center for the Study of Drug Development (CSDD) today published a white paper sharing study results that indicate Quotient Sciences’ Translational Pharmaceutics® platform reduces development times by more than 12 months and lo...

The future of value-added medicines will see gamification transforming the engagement of therapies.

Recipharm expects cost synergies of SEK 125 million (USD 12 million) from its recent acquisition of UK drug delivery firm Consort Medical and should realise them within the next 18 months, the Swedish contract research and development organisation (CDM...

The investment will support continued expansion into the fast-growing gene therapy segment, including new developments that will enable a range of best-in-class solutions for viral manufacturing.

Boehringer Ingelheim and Carebox Healthcare Solutions have launched a digital platform to provide patients, caregivers and doctors with information on the German drugmaker’s clinical trials.

A subsidiary of WuXi Biologics has signed a 20-year vaccine manufacturing contract worth around USD 3 billion with a global vaccine company, the Chinese contract development and manufacturing organisation (CDMO) said Tuesday.

The expansion will enable Putnam Associates to access the European market and to offer more localised support to its clients.

Deal sees 62 brands in multiple therapy areas and a manufacturing plant transfer to the company

Pharmaceutical companies need to change their mindset and focus more on delivering extra value from smart packaging rather than reducing the cost of their packaging operation, according to Alex Cole, senior strategic marketing manager at CPI.

Investment in resources to meet demand for large-scale supply of patented biocompatible surfactant.

Event move ensures extra precautions and safety measures taken

Developers of digital health tools designed to improve adherence to medicines need to make behavioural science the cornerstone of their strategy if they are to keep patients engaged and motivated, according to Paul Upham, Head of Smart Devices at Roche...

The company aims to simplify its customers’ work and thus help them to achieve medical progress and make innovative medicines available faster.

Gene therapies have the potential to revolutionize treatment options for patients suffering from cancer, cystic fibrosis, heart disease, diabetes, Parkinson's, AIDS and Alzheimer's by replacing, inactivating or introducing genes into cells &mda...

The inspection was triggered by data generated by MedPharm as part of a client’s ANDA for a generic topical product.

The changing opportunities are attributed to rising GMP standards and increased regional harmonization.

EuTech has recently added two strong professionals in its Management Team. Shekhar Yerramilli has joined as COO and Rick Yglesias has joined as Head of Business Development.

Stevanato and Pfeiffer Vacuum will provide biopharma companies with advanced container closure integrity analysis and testing protocols.

Merck KGaA’s US life science arm, MilliporeSigma, has signed a global licence agreement with biologics technology firm ReForm Biologics to commercialize the latter’s proprietary excipients used in biotherapeutic formulations.

PCI Pharma Services has bought Toronto-based packaging and labelling specialist Bellwyck Pharma Services, adding four GMP-compliant facilities in the US, Germany and Canada to its global network, the CDMO announced Tuesday.

Biopharmaceutical outsourcing has increased markedly in recent years with a greater volume of work previously kept in-house being handed over to third party contractors

Innovations across primary and secondary packaging, drug delivery devices, and machinery acknowledged in Exhibitor Innovations, with Health Product Awards for patient-centricity and eco-design.

Lonza will invest CHF 12 million (USD 12.3 million) in a catalytic convertor at its Visp manufacturing site to reduce annual emissions of carbon dioxide by 600,000 tons or 98%, the Switzerland-based contract development and manufacturing organisation (...

Rising pharmaceutical cost pressures and volume growth deceleration are forcing pharmaceutical companies to attempt to extract further value from existing medicines rather than solely pursuing new molecules, according to Aurelio Arias, Engagement Manag...

Zenith Technologies CEO, Joe Haugh, takes us through how the business has evolved this year, to better meet the needs of its customers, as well as the trends they see shaping the industry through 2020 and beyond.

CEO says the acquisition of Consort Medical will help to create a leading advanced delivery systems company.

The facility will triple the company’s cGMP clinical trial manufacturing capacity.

TwinMax enabes delivery of doses up to 100 mg formulated as drug alone or engineered particles.

The additional capacity will provide customers with shorter lead times and reduced transportation costs.

Bundling of competencies optimizes workflow of customer projects.

Delpharm and the Famar Group are pleased to announce the acquisition by Delpharm of 5 manufacturing sites belonging to Famar, in France, Canada and the Netherlands. The transaction signed today covers the French sites located in Orléans (Loiret), ...

With CPHI North America fast approaching, we asked several industry experts what they see as the main trends emerging across the US pharma supply chain this year.

Evolving patient needs, growing demand for traceability and increasing cost pressures have awakened innovation in the pharmaceutical packaging sector.

Trijardy XR is a once-daily therapy combining three well-established treatments in one pill.

Sai Life Sciences has initiated the recruitment of 300+ scientists for its upcoming integrated Research & Technology (R&T) centre in Hyderabad, India. This will result in doubling the full-time equivalents (FTEs) in the areas of discovery chemist...

A new drug candidate has been created by artificial intelligence (AI) for the very first time, with the exploratory research route to phase I clinical trials taking less than 12 months, considerably shorter than the typical four and a half years using ...

Amid heightened global concern over the recent coronavirus outbreak, Chinese CDMO WuXi Biologics has sought to reassure customers and patients that its drug supply lines have been unaffected.

ALPLApharma, a new brand of the global packaging specialist ALPLA Group, will introduce itself for the first time to industry professionals at the CPHI Worldwide exhibition.

Agreement will facilitate clinical trial translations in China.

The US Food and Drug Administration has issued India’s Dr Reddy’s Laboratories with five observations after a recent inspection at its active pharmaceutical ingredient (API) manufacturing plant at Srikakulam.

Pharmapack also identifies waste management and the use of blockchain as key trends for the year ahead.

German company Merck KGaA is investing Euro 250 million in a Swiss biologics facility that bridges manufacturing and research.

As manufacturing industries continue to promote the diverse roles available in science, technology, engineering and mathematics (STEM) disciplines, we turn the spotlight on careers in chemical manufacturing…

Canadian investment firm Nabis Holdings said Tuesday it has agreed to form a joint venture with Israeli pharmaceutical company Panaxia to launch a range of cannabis-based pharmaceutical products in the US state of Arizona in the second half of 2020.

Cognate BioServices, a contract development and manufacturing organization specialising in cell and gene therapy, has completed its purchase of Cobra Biologics, a CDMO specialized in providing development and manufacturing services for plasmid DNA and ...

Biotech firm CNS Pharmaceuticals said Tuesday it has completed pilot manufacturing of a key active pharmaceutical ingredient for its brain tumor drug Berubicin, taking it closer to clinical trials.

If proven safe and effective, mAb CIS43LS might be used prophylactically by tourists, medical workers or military personnel who travel to areas where malaria is common.

Indian CDMO Piramal Pharma Solutions said Tuesday it will invest C$25 million to expand the capacity of its Aurora facility in Canada by 10,500 square feet to house a new wing for manufacturing active pharmaceutical ingredients (APIs).

€250 million to be invested during the 2019-2022 period in new facility bridging research and manufacturing.